Submitted:
05 August 2025
Posted:
08 August 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
Study Design and Population
Cardiovascular Risk Assessment Tools
Clinical and Biochemical Measurements
Study Objectives
Statistical Analysis
Ethical Considerations
3. Results
Characteristics of the Respondents
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Gielerak, G.; Krzesiński, P.; Piotrowicz, K.; Murawski, P.; Skrobowski, A.; Stańczyk, A.; Galas, A.; Uziębło-Życzkowska, B.; Kaźmierczak-Dziuk, A.; Maksimczuk, J.; et al. The Prevalence of Cardiovascular Risk Factors among Polish Soldiers: The Results from the MIL-SCORE Program. Cardiol. Res. Pract. 2020, 2020, 1–7. [Google Scholar] [CrossRef] [PubMed]
- Yusuf, S.; Hawken, S.; Ôunpuu, S.; Dans, T.; Avezum, A.; Lanas, F.; McQueen, M.; Budaj, A.; Pais, P.; Varigos, J.; et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet 2004, 364, 937–952. [Google Scholar] [CrossRef]
- Antynomie systemu ochrony zdrowia; Polska Akademia Nauk: Warszawa, 2021; ISBN 978-83-66847-10-1.
- Rekomendacja nr 1/2023 Prezesa AOTMiT z 29 grudnia 2023 r. w sprawie zalecanych technologii medycznych, działań przeprowadzanych w ramach programów polityki zdrowotnej oraz warunków realizacji tych programów, dotyczących profilaktyki uzależnień od tytoniu (nikotyny). Agencja Oceny Technol. Med. Taryfikacji 2023.
- Martin, S.S.; Aday, A.W.; Almarzooq, Z.I.; Anderson, C.A.M.; Arora, P.; Avery, C.L.; Baker-Smith, C.M.; Barone Gibbs, B.; Beaton, A.Z.; Boehme, A.K.; et al. 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation 2024, 149, e347–e913. [Google Scholar] [CrossRef]
- Lach, J.; Bzdęga, J.; Kubiak, L.; Ostalska, J.; Żbikowski, J.; Nieporęcki, R. Wojskowe zakłady lecznicze armii polskiej. Część I. Chorzy leczeni w latach 1922–1931 na podstawie sprawozdania gen. Stanisława Roupperta do Marszałka Józefa Piłsudskiego. Hygeia Public Health 49, 774–778.
- Trzeciak, B.G.; Kowalczyk, W.; Grymek, S.; Gutknecht, P.; Siebert, J. Cardiovascular risk factors among Polish employees of uniformed services. Int. J. Occup. Med. Environ. Health 2023, 36, 656–671. [Google Scholar] [CrossRef]
- Vemu, P.L.; Yang, E.; Ebinger, J. 2023 ESH hypertension guideline update: Bringing us closer together across the pond. Am. Coll. Cardiol. 2024. [Google Scholar]
- De Backer, G. European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). Eur. Heart J. 2003, 24, 1601–1610. [Google Scholar] [CrossRef]
- Conroy, R. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur. Heart J. 2003, 24, 987–1003. [Google Scholar] [CrossRef] [PubMed]
- SCORE2 working group and ESC Cardiovascular risk collaboration; Hageman, S. ; Pennells, L.; Ojeda, F.; Kaptoge, S.; Kuulasmaa, K.; De Vries, T.; Xu, Z.; Kee, F.; Chung, R.; et al. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur. Heart J. 2021, 42, 2439–2454. [Google Scholar] [CrossRef] [PubMed]
- Zdrojewski, T.; Jankowski, P.; Bandosz, P.; Bartuś, S.; Chwojnicki, K.; Drygas, W.; Gaciong, Z.; Hoffman, P.; Kalarus, Z.; Kaźmierczak, J.; et al. A new version of cardiovascular risk assessment system and risk charts calibrated for Polish population. Kardiol. Pol. 2015, 73, 958–961. [Google Scholar] [CrossRef] [PubMed]
- Csenteri, O.; Jancsó, Z.; Szöllösi, G.J.; Andréka, P.; Vajer, P. Differences of cardiovascular risk assessment in clinical practice using SCORE and SCORE2. Open Heart 2022, 9, e002087. [Google Scholar] [CrossRef]
- Boskovic, N.; Giga, V.; Djordjevic-Dikic, A.; Beleslin, B.; Stojkovic, S.; Nedeljkovic, I.; Aleksandric, S.; Tesic, M.; Dedic, S.; Burazor, I.; et al. Comparison of SCORE and SCORE 2 risk prediction tools in contemporary very high risk european population. Eur. Heart J. 2022, 43, ehac544.2281. [Google Scholar] [CrossRef]
- Rzepka-Cholasinska, A.; Kasprzak, M.; Michalski, P.; Pietrzykowski, Ł.; Grzelakowska, K.; Kubica, A.-. Cardiovascular risk assessment based on SCORE and SCORE2. Med. Res. J. 2022, 7, 164–169. [Google Scholar] [CrossRef]
- Selmer, R.; Lindman, A.S.; Tverdal, A.; Pedersen, J.I.; Njølstad, I.; Veierød, M.B. Modell for estimering av kardiovaskulaer risiko i Norge. Tidsskr. Den Nor. Laegeforening Tidsskr. Prakt. Med. Ny Raekke 2008, 128, 286–290. [Google Scholar]
- Svinin, G.E.; Kutsenko, V.A.; Shalnova, S.A.; Yarovaya, E.B.; Imaeva, A.E.; Balanova, Y.A.; Kapustina, A.V.; Muromtseva, G.A.; Drapkina, O.M. Validation of SCORE2 on a sample from the Russian population and adaptation for the very high cardiovascular disease risk region. PLOS ONE 2024, 19, e0300974. [Google Scholar] [CrossRef] [PubMed]
- Vincent, S.R.; Schlenk, M.A.; Horan, K.A.; Moore, B.A. Incidences and trends of cardiovascular determinants and diagnoses in active duty service members. J. Mil. Veterans Health 32.
- Pavlík, V.; Šafka, V.; Pravdová, L.; Urban, M.; Lašák, P.; Tuček, M. Comparison of selected risk factors in cardiovascular diseases in two different populations of the Czech Republic. Cent. Eur. J. Public Health 2020, 28, S47–S52. [Google Scholar] [CrossRef]
- Zimmerman, F.H. Cardiovascular Disease and Risk Factors in Law Enforcement Personnel: A Comprehensive Review. Cardiol. Rev. 2012, 20, 159–166. [Google Scholar] [CrossRef]
- Gendron, P.; Lajoie, C.; Laurencelle, L.; Trudeau, F. Cardiovascular health profile among Québec male and female police officers. Arch. Environ. Occup. Health 2019, 74, 331–340. [Google Scholar] [CrossRef]
- Zawadzka, M.; Marszałkowska-Jakubik, J.; Ejchman-Pac, E.; Pająk-Tarnacka, B.; Szymański, P. Assessing Cardiovascular Risk Among Polish Soldiers: Insights Using the POL SCORE Tool. J. Clin. Med. 2025, 14, 2130. [Google Scholar] [CrossRef]
- Vaicaitiene, R.; Cerniauskiene, L.R.; Luksiene, D.I.; Margeviciene, L. Hypercholesterolemia and Smoking Habits of Lithuanian Military Personnel. Mil. Med. 2006, 171, 512–515. [Google Scholar] [CrossRef] [PubMed]
- MON do żołnierzy: rzućcie palenie 2011.
- W obiektach MON będzie można używać wyrobów tytoniowych tylko w palarniach. W pojazdach trzeba będzie zapytać o zgodę pasażerów. 2024.
- Webber, B.J.; Bornstein, D.B.; Kiel, M.A.; Wilkins, R.C.; Bryant, C.X. Physical Activity and the Health of a Nation: A National Challenge and Collective Response. Am. J. Lifestyle Med. 2024, 18, 632–637. [Google Scholar] [CrossRef] [PubMed]
- Santos, A.R.D.; Ihlenfeld, M.F.K.; Olandoski, M.; Barreto, F.C. Comparative analysis of the health status of military police officers and firefighters: a cross-sectional study in the State of Paraná, Brazil. BMJ Open 2022, 12, e049182. [Google Scholar] [CrossRef]
- World Obesity Atlas 2023. 17 World Obes. Fed. 2023.
- Combating military obesity: Understanding the problem and developing solutions. Wash. DC Am. Secur. Proj.
- Rosellini, A.J.; Stein, M.B.; Benedek, D.M.; Bliese, P.D.; Chiu, W.T.; Hwang, I.; Monahan, J.; Nock, M.K.; Petukhova, M.V.; Sampson, N.A.; et al. Using self-report surveys at the beginning of service to develop multi-outcome risk models for new soldiers in the U.S. Army. Psychol. Med. 2017, 47, 2275–2287. [Google Scholar] [CrossRef]
- McBride, D.; Samaranayaka, A.; Richardson, A.; Gardner, D.; Shepherd, D.; Wyeth, E.; De Graaf, B.; Derrett, S. Factors associated with self-reported health among New Zealand military veterans: a cross-sectional study. BMJ Open 2022, 12, e056916. [Google Scholar] [CrossRef] [PubMed]










| GUIDELINE DIFFERENCES | 2017 ACC/AHA | 2023 ECH |
|---|---|---|
| hypertension definition | ≥ 130/80 | ≥ 130/80 |
| normal BP ranges (mmHg) | Normal: < 120/80 Elevated: 120129/<80 |
Optimal: <120/80 Normal: 120-129/80-84 High-Normal: 130-139/85-89 |
| hypertensive BP ranges (mmHg) | Hypertension Stage 1: 130-139/80-89 Hypertension Stage 2: ≥ 140/90 |
Hypertension Grade 1: 14-159/90-99 Hypertension Grade 2: 160-179/100-109 Hypertension Grade 3: ≥180/110 |
| BP targets for treatment | ||
| 18 - 64 years (mmHg) | < 130/80 | < 130/80 |
| 65 - 79 years (mmHg) | < 130/80 | < 140/80 |
| ≥ 80 years (mmHg) | < 130/80 | 140-150/<80 |
| VARIABLES | SD | Me | min | max | |||
|---|---|---|---|---|---|---|---|
| TOTAL | systolic blood pressure | 138.98 | 15.96 | 136.00 | 104.00 | 190.00 | |
| total cholesterol | 231.01 | 44.79 | 225.00 | 121.00 | 459.60 | ||
| non-HDL cholesterol | 169.10 | 44.60 | 168.00 | 50.00 | 380.20 | ||
| Age | 47.83 | 5.32 | 47.00 | 40.00 | 67.00 | ||
| Pol-SCORE | LOW | systolic blood pressure | 131.69 | 9.02 | 132.5 | 115.00 | 145.00 |
| total cholesterol | 212.6 | 31.77 | 203.00 | 172.20 | 304.00 | ||
| non-HDL cholesterol | 145.49 | 33.28 | 139.65 | 94.10 | 235.00 | ||
| Age | 42.19 | 1.60 | 43.00 | 40.00 | 44.00 | ||
| MODERATE | systolic blood pressure | 135.69 | 13.99 | 135.00 | 104.00 | 170.00 | |
| total cholesterol | 228.69 | 46.45 | 228.00 | 121.00 | 459.60 | ||
| non-HDL cholesterol | 166.00 | 45.22 | 166.00 | 50.00 | 380.00 | ||
| Age | 46.98 | 4.71 | 46.00 | 40.00 | 67.00 | ||
| HIGH | systolic blood pressure | 149.04 | 17.59 | 150.00 | 114.00 | 190.00 | |
| total cholesterol | 240.64 | 40.78 | 234.85 | 167.00 | 321.00 | ||
| non-HDL cholesterol | 183.07 | 40.42 | 182.65 | 107.7 | 253.00 | ||
| Age | 51.07 | 4.38 | 51.00 | 40.00 | 64.00 | ||
| VERY HIGH | systolic blood pressure | 157.00 | 15.69 | 150.00 | 140.00 | 189.00 | |
| total cholesterol | 258.60 | 44.85 | 268.00 | 185.60 | 323.60 | ||
| non-HDL cholesterol | 197.10 | 49.54 | 209.00 | 110.70 | 248.60 | ||
| Age | 57.00 | 5.50 | 56.00 | 51.00 | 67.00 | ||
| SCORE2 | LOW | systolic blood pressure | 131.94 | 11.60 | 133.00 | 104.00 | 170.00 |
| total cholesterol | 225.09 | 43.97 | 220.00 | 121.00 | 340.00 | ||
| non-HDL cholesterol | 154.80 | 41.68 | 153.00 | 50.00 | 273.00 | ||
| Age | 47.09 | 4.82 | 46.00 | 40.00 | 59.00 | ||
| HIGH | systolic blood pressure | 144.29 | 16.67 | 142.00 | 112.00 | 190.00 | |
| total cholesterol | 232.17 | 45.66 | 222.20 | 130.00 | 459.60 | ||
| non-HDL cholesterol | 176.56 | 42.89 | 170.10 | 75.00 | 380.20 | ||
| Age | 47.74 | 5.43 | 47.00 | 40.00 | 67.00 | ||
| VERY HIGH | systolic blood pressure | 151.06 | 16.24 | 150.00 | 119.00 | 189.00 | |
| total cholesterol | 259.06 | 34.67 | 265.00 | 168.00 | 323.60 | ||
| non-HDL cholesterol | 211.65 | 33.78 | 216.20 | 135.00 | 253.00 | ||
| Age | 52.50 | 5.42 | 52.00 | 43.00 | 67.00 | ||
| VARIABLES | Pol-SCORE | SCORE2 | ||||||
|---|---|---|---|---|---|---|---|---|
| low | moderate | high | very high | Low | high | very high | ||
| gender [%] | Male | - | 66.43 | 28.57 | 5.00 | 33.57 | 55.71 | 10.72 |
| Female | 28.57 | 67.86 | 3.57 | - | 82.14 | 16.07 | 1.79 | |
| study group [%] | Soldier | 10.53 | 74.34 | 14.47 | 0.66 | 59.21 | 38.82 | 1.97 |
| civilian worker | 40.91 | - | 45.45 | 13.64 | 6.82 | 63.64 | 29.55 | |
| military services corps [%] | private soldier | 12.50 | 62.50 | 25.00 | - | 25.00 | 75.00 | - |
| non-commissioned oficer | 5.68 | 63.64 | 28.41 | 2.27 | 37.50 | 53.41 | 9.09 | |
| junior oficer | 5.00 | 70.00 | 20.00 | 5.00 | 50.00 | 45.00 | 5.00 | |
| senior oficer | 2.94 | 67.65 | 20.59 | 8.82 | 38.24 | 44.12 | 17.64 | |
| general, admiral | - | 66.67 | 33.33 | - | 66.67 | 33.33 | - | |
| Lack | 18.60 | 72.09 | 6.98 | 2.33 | 76.74 | 20.93 | 2.33 | |
| Variables | Pol-SCORE | SCORE2 | ||||||
|---|---|---|---|---|---|---|---|---|
| low | moderate | high | very high | low | high | very high | ||
| self-awareness in preventing cardiovascular diseases | yes | 86.67 | 92.31 | 97.62 | 100.00 | 92.39 | 93.02 | 100.00 |
| no | 13.33 | 7.69 | 2.38 | - | 7.61 | 6.98 | - | |
| variables | Pol-SCORE | SCORE2 | ||||||
|---|---|---|---|---|---|---|---|---|
| low | moderate | high | very high | low | high | very high | ||
| occurrence of cardiovascular diseases in the family | yes | 66.67 | 48.82 | 35.72 | 42.86 | 51.11 | 45.88 | 31.25 |
| no | 20.00 | 34.65 | 54.76 | 42.86 | 31.11 | 43.53 | 50.00 | |
| no opinion | 13.33 | 16.53 | 9.52 | 14.28 | 17.78 | 10.59 | 18.75 | |
| variables | Pol-SCORE | SCORE2 | ||||||
|---|---|---|---|---|---|---|---|---|
| low | moderate | high | very high | Low | high | very high | ||
| chest pain | yes | 6.67 | 10.24 | 4.76 | - | 11.11 | 7.06 | - |
| no | 93.33 | 89.76 | 95.24 | 100.00 | 88.89 | 92.94 | 100.00 | |
| Statistics | H=1.973; p=0.5778 | H=2.518; p=0.2839 | ||||||
| dyspnoea | Yes | 13.33 | 6.30 | 2.38 | 14.29 | 8.89 | 2.35 | 12.50 |
| No | 86.67 | 93.70 | 97.62 | 85.71 | 91.11 | 97.65 | 87.50 | |
| Statistics | H=3.097; p=0.3768 | H=4.295; p=0.1168 | ||||||
| dizziness | Yes | - | 8.66 | 4.76 | - | 7.78 | 5.88 | 6.25 |
| No | 100.00 | 91.34 | 95.24 | 100.00 | 92.22 | 94.12 | 93.75 | |
| Statistics | H=2.559; p=0.4647 | H=0.254; p=0.8804 | ||||||
| heart palpitations | Yes | 13.33 | 14.17 | 7.14 | 28.57 | 15.56 | 10.59 | 12.50 |
| No | 86.67 | 85.83 | 92.86 | 71.43 | 84.44 | 89.41 | 87.50 | |
| Statistics | H=2.897; p=0.4078 | H=0.948; p=0.6224 | ||||||
| pain in the lower limbs | Yes | 6.67 | 13.39 | 7.14 | 14.29 | 15.56 | 5.88 | 18.75 |
| No | 93.33 | 86.61 | 92.86 | 85.71 | 84.44 | 94.12 | 81.25 | |
| Statistics | H=1.614; p=0.6562 | H=4.883; p=0.0870 | ||||||
| headache | Yes | 60.00 | 35.43 | 26.19 | 14.29 | 42.22 | 24.71 | 43.75 |
| No | 40.00 | 64.57 | 73.81 | 85.71 | 57.78 | 75.29 | 56.25 | |
| Statistics | H=6.872; p=0.0761 | H=6.549; p=0.0378 | ||||||
| increased blood pressure | Yes | - | 24.41 | 30.95 | 28.57 | 16.67 | 32.94 | 18.75 |
| No | 100.00 | 75.59 | 69.05 | 71.43 | 83.33 | 67.06 | 81.25 | |
| Statistics | H=5.895; p=0.1168 | H=6.569; p=0.0374 | ||||||
| Variables | Pol-SCORE | SCORE2 | ||||||
|---|---|---|---|---|---|---|---|---|
| low | moderate | high | very high | Low | high | very high | ||
| overweight | Yes | 14.29 | 34.15 | 40.48 | 28.57 | 27.91 | 36.09 | 50.00 |
| No | 85.71 | 65.85 | 59.52 | 71.43 | 72.09 | 63.10 | 50.00 | |
| Statistics | H=3.289; p=0.3491 | H=3.549; p=0.1695 | ||||||
| Obesity | Yes | 14.29 | 14.63 | 26.19 | 14.29 | 13.95 | 16.67 | 37.50 |
| No | 85.71 | 85.37 | 73.81 | 85.71 | 86.05 | 83.33 | 62.50 | |
| Statistics | H=3.060; p=0.3824 | H=5.253; p=0.0723 | ||||||
| incorrect diet | Yes | 42.86 | 41.46 | 47.62 | 42.86 | 40.70 | 41.67 | 62.50 |
| No | 57.14 | 58.54 | 52.38 | 57.14 | 59.30 | 58.33 | 37.50 | |
| Statistics | H=0.481; p=0.9229 | H=2.714; p=0.2574 | ||||||
| increased cholesterol levels | Yes | 7.14 | 15.45 | 38.10 | 14.29 | 11.63 | 22.62 | 50.00 |
| No | 92.86 | 84.55 | 61.90 | 85.71 | 88.37 | 77.38 | 50.00 | |
| Statistics | H=11.760; p=0.0082 | H=13.108; p=0.0014 | ||||||
| low physical activity | Yes | 35.71 | 20.33 | 28.57 | 14.29 | 25.58 | 16.67 | 43.75 |
| No | 64.29 | 79.67 | 71.43 | 85.71 | 74.42 | 83.33 | 56.25 | |
| Statistics | H=2.784; p=0.4261 | H=6.059; p=0.0483 | ||||||
| smoking | Yes | 7.14 | 17.07 | 45.24 | 28.57 | 8.14 | 30.95 | 62.50 |
| No | 92.86 | 82.93 | 54.76 | 71.43 | 91.86 | 69.05 | 37.50 | |
| Statistics | H=16.131; p=0.0011 | H=27.569; p=0.0000 | ||||||
| drinking alcohol | Yes | 7.14 | 17.07 | 30.95 | 14.29 | 15.12 | 20.24 | 37.50 |
| No | 92.86 | 82.93 | 69.05 | 85.71 | 84.88 | 79.76 | 62.50 | |
| Statistics | H=5.452; p=0.1415 | H=4.383; p=0.1117 | ||||||
| Stress | Yes | 71.43 | 59.35 | 54.76 | 28.57 | 60.47 | 55.95 | 56.25 |
| no | 28.57 | 40.65 | 45.24 | 71.43 | 39.53 | 44.05 | 43.75 | |
| Statistics | H=3.778; p=0.2864 | H=0.377; p=0.8282 | ||||||
| Variables | Pol-SCORE | SCORE2 | ||||||
|---|---|---|---|---|---|---|---|---|
| low | moderate | high | very high | Low | high | very high | ||
| self-assessment of health | very good | 26.67 | 18.03 | 16.67 | 28.57 | 18.60 | 19.05 | 18.75 |
| good | 53.33 | 59.84 | 61.90 | 42.86 | 58.14 | 60.72 | 56.25 | |
| sufficient | 13.33 | 10.66 | 11.90 | 28.57 | 10.47 | 11.90 | 18.75 | |
| wrong | - | 0.81 | - | - | 1.16 | - | - | |
| no opinion | 6.67 | 10.66 | 9.53 | - | 11.63 | 8.33 | 6.25 | |
| Variables | Pol-SCORE | SCORE2 | ||||||
|---|---|---|---|---|---|---|---|---|
| low | moderate | high | very high | low | high | very high | ||
| frequency of preventive tests for cardiovascular diseases | more than once a year | - | 8.13 | 2.38 | - | 8.05 | 4.76 | - |
| once a year | 6.67 | 23.57 | 42.86 | 57.14 | 18.39 | 35.71 | 37.50 | |
| once every 5 years | 13.33 | 12.20 | 9.52 | 28.57 | 13.79 | 10.71 | 12.50 | |
| when I have symptoms | 20.00 | 8.13 | 4.76 | - | 8.05 | 8.33 | 6.25 | |
| only periodic tests at work | 46.67 | 42.28 | 40.48 | 14.29 | 45.98 | 35.71 | 43.75 | |
| I don’t get tested | 13.33 | 5.69 | - | - | 5.74 | 4.76 | - | |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
